BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30618472)

  • 1. Induction of Psychosis by Cyclobenzaprine.
    Cohen JY; Guilbault A
    Psychopharmacol Bull; 2018 Jun; 48(4):15-19. PubMed ID: 30618472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis following cyclobenzaprine use.
    Beeber AR; Manring JM
    J Clin Psychiatry; 1983 Apr; 44(4):151-2. PubMed ID: 6833204
    [No Abstract]   [Full Text] [Related]  

  • 3. First episode psychosis following cyclobenzaprine use.
    O'Neil BA; Knudson GA; Bhaskara SM
    Can J Psychiatry; 2000 Oct; 45(8):763-4. PubMed ID: 11086564
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclobenzaprine hydrochloride is a commonly prescribed centrally acting muscle relaxant, which is structurally similar to tricyclic antidepressants (TCAs) and differs from amitriptyline by only one double bond.
    Lofland JH; Szarlej D; Buttaro T; Shermock S; Jalali S
    Clin J Pain; 2001 Mar; 17(1):103-4. PubMed ID: 11289081
    [No Abstract]   [Full Text] [Related]  

  • 5. Five-year multicenter retrospective review of cyclobenzaprine toxicity.
    Spiller HA; Winter ML; Mann KV; Borys DJ; Muir S; Krenzelok EP
    J Emerg Med; 1995; 13(6):781-5. PubMed ID: 8747627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric side effects of cyclobenzaprine.
    Shprecher D; Sloan CT; Sederholm B
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdose of cyclobenzaprine, the tricyclic muscle relaxant.
    O'Riordan W; Gillette P; Calderon J; Stennes RL
    Ann Emerg Med; 1986 May; 15(5):592-3. PubMed ID: 2870671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exudative Erythema Multiforme Due to Cyclobenzaprine.
    Gómez Torrijos E; García Arpa M; García Rodríguez C; Mendez Díaz Y; Borja Segade J; Galindo Bonilla PA; Feo Brito JF; García Rodríguez R
    J Investig Allergol Clin Immunol; 2016; 26(4):265-6. PubMed ID: 27470645
    [No Abstract]   [Full Text] [Related]  

  • 9. Torticollis under cyclobenzaprine.
    Reuss R; Reuter I; Jauss M; Fischer F; Muller SC; Stolz E
    Pharmacology; 2009; 84(2):91-2. PubMed ID: 19590258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal use of cyclobenzaprine (Flexeril) may induce ductal closure and persistent pulmonary hypertension in neonates.
    Moreira A; Barbin C; Martinez H; Aly A; Fonseca R
    J Matern Fetal Neonatal Med; 2014 Jul; 27(11):1177-9. PubMed ID: 24102182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.
    Mestres J; Seifert SA; Oprea TI
    Clin Pharmacol Ther; 2011 Nov; 90(5):662-5. PubMed ID: 21975349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tinnitus with cyclobenzaprine: an open-label study.
    Vanneste S; Figueiredo R; De Ridder D
    Int J Clin Pharmacol Ther; 2012 May; 50(5):338-44. PubMed ID: 22541838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs.
    Keegan MT; Brown DR; Rabinstein AA
    Anesth Analg; 2006 Dec; 103(6):1466-8. PubMed ID: 17122225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of interference by cyclobenzaprine in liquid-chromatographic assays of tricyclic antidepressants.
    Puopolo PR; Flood JG
    Clin Chem; 1987 Jun; 33(6):819-20. PubMed ID: 3594825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.
    Bennett RM; Gatter RA; Campbell SM; Andrews RP; Clark SR; Scarola JA
    Arthritis Rheum; 1988 Dec; 31(12):1535-42. PubMed ID: 3058130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclobenzaprine on tricyclic antidepressant assays.
    Van Hoey NM
    Ann Pharmacother; 2005; 39(7-8):1314-7. PubMed ID: 15956237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of cyclobenzaprine and tricyclic antidepressants.
    Rosenlicht NZ; Riley-Lazo KP
    J Clin Psychiatry; 2005 Jan; 66(1):134-5. PubMed ID: 15669899
    [No Abstract]   [Full Text] [Related]  

  • 18. An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine.
    Caron J; Kaye R; Wessel T; Halseth A; Kay G
    J Clin Pharm Ther; 2020 Aug; 45(4):774-782. PubMed ID: 32390248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.
    Carette S; Bell MJ; Reynolds WJ; Haraoui B; McCain GA; Bykerk VP; Edworthy SM; Baron M; Koehler BE; Fam AG
    Arthritis Rheum; 1994 Jan; 37(1):32-40. PubMed ID: 8129762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.